Successful olaparib desensitization using a novel one-day protocol
Abstract Background Olaparib is a revolutionary treatment for patients with ovarian and breast cancer. Currently, there is no established 1-day drug desensitization protocol for patients with olaparib type-1 hypersensitivity reactions despite well documented IgE-mediated adverse reactions occurring...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-11-01
|
| Colecção: | Allergy, Asthma & Clinical Immunology |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s13223-020-00499-x |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|